Robert Essner insider trades

Open-market stock purchases and sales by Robert Essner, Director at Organon & Co, from SEC Form 4 filings since Jul 9, 2012.

Recent trades

DateStockTradeValue
Jun 12, 2026OGN Organon & CoBought (not open market)$240K

Companies traded

  • OGN Organon & Co: other filings, last Jun 12, 2026
  • FOLD Amicus Therapeutics, Inc: other filings, last Jun 10, 2021

Get free alerts when Robert Essner files a new trade →